Amgen Inc $140.71

up +1.38


17/9/2014 04:15 PM  |  NASDAQ : AMGN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AMGN Trend Analysis - it has outperformed the S&P 500 by 4%

Partner Headlines

  1. Amgen, Inc. Poised To Break Higher

    Benzinga
  2. UPDATE: Morgan Stanley Reiterates On Amgen, Inc. As Brodalumab Doesn't ...

    Benzinga
  3. UPDATE: Morgan Stanley Reiterates On Amgen, Inc. Following Healthcare Conference

    Benzinga
  4. Amgen, Inc. Showing More Upside Potential

    Benzinga
  5. Why Gilead Sciences, Inc. Is A Top Mutual Fund Holding

    Benzinga
  6. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD
  7. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD
  8. Amgen edges up on trial results

    IBD
  9. Stocks Hitting 52-Week Highs

    Benzinga
  10. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga
  11. After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

    GuruFocus
  12. HCP Boosts Of 29 Years Of Dividend Increases

    IBD
  13. The Tech Industry is Vanishing Before Our Eyes

    FoxBusiness
  14. Stocks End With Small Gains; Amgen Shrugs Off Drug Data

    IBD
  15. AMGEN

    IBD
  16. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  17. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  18. Cancer 'Cocktail' Passes Test

    IBD
  19. Nasdaq Leads In Quiet Session; Priceline Nears Buy Point

    IBD
  20. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  21. Morning Market Movers

    Benzinga
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. UPDATE: Amgen Announces Phase 3 ASPIRE Trial of Kyprolis Met Primary Endpoint, ...

    Benzinga
  24. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  25. Amgen Price Target Raised by Various Analysts

    Benzinga
  26. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD
  27. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  28. Amgen To Slash Workforce

    IBD
  29. Indexes End Lower As Russia Sanctions Hit Stocks

    IBD
  30. Stock Futures Show Some Muscle; Merck, Cognex Rising

    IBD
  31. Earnings Scheduled For July 29, 2014

    Benzinga
  32. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  33. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  34. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  35. US Stock Futures Drop Ahead Of Durable Goods Orders Data

    Benzinga
  36. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  37. UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment ...

    Benzinga
  38. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  39. Morgan Stanley Issues 2015 'Vintage Values' Stock List

    Benzinga
  40. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  41. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  42. Bind Therapeutics

    IBD
  43. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  44. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  45. Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%

    Benzinga
  46. Morning Market Losers

    Benzinga
  47. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  48. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  49. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  50. UPDATE: Morgan Stanley Reiterates On Amgen On New CFO

    Benzinga
Trading Center